Evaluation of Thoracic Tumors With 18F-FMT and 18F-FDG PET-CT A Clinicopathological Study

This study has been completed.
Sponsor:
Collaborator:
J~pharma
Information provided by:
Gunma University
ClinicalTrials.gov Identifier:
NCT00698373
First received: June 12, 2008
Last updated: June 16, 2008
Last verified: June 2008
  Purpose

L-[3-18F]-α-methyltyrosine (18F-FMT) is an amino-acid tracer for positron emission tomography (PET). The aim of this study was to determine whether PET-CT with 18F-FMT provides additional information for the preoperative diagnostic workup as compared with 18F-FDG PET. Tumor uptake of 18F-FMT was compared with several immunohistochemical markers including L-type amino acid transporter 1 (LAT1).


Condition
Non-Small Cell Lung Cancer

Study Type: Observational
Study Design: Time Perspective: Prospective
Official Title: Evaluation of Thoracic Tumors With 18F-FMT and 8F-FDG PET-CT: A Clinicopathological Study

Resource links provided by NLM:


Further study details as provided by Gunma University:

Groups/Cohorts
1
PET study

  Eligibility

Ages Eligible for Study:   20 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

Patients with indeterminate pulmonary nodule suspicious of lung cancer were eligible for this prospective study.

Criteria

Inclusion Criteria:

  • Patients with indeterminate pulmonary nodule suspicious of lung cancer

Exclusion Criteria:

  • Patients with other malignancies and those who had received cancer treatment within the past 5 years were excluded.
  Contacts and Locations
No Contacts or Locations Provided
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00698373     History of Changes
Other Study ID Numbers: Molecular FMT imaging
Study First Received: June 12, 2008
Last Updated: June 16, 2008
Health Authority: Japan: Ministry of Health, Labor and Welfare

Keywords provided by Gunma University:
Fluorine-18-α-methyltyrosine,
Positron emission tomography,
Fluorine-18-fluorodeoxyglucose,
Lung cancer,

Additional relevant MeSH terms:
Carcinoma, Non-Small-Cell Lung
Lung Neoplasms
Thoracic Neoplasms
Carcinoma, Bronchogenic
Bronchial Neoplasms
Respiratory Tract Neoplasms
Neoplasms by Site
Neoplasms
Lung Diseases
Respiratory Tract Diseases

ClinicalTrials.gov processed this record on April 17, 2014